| Income Statement |
| Total Revenue | 191.06B |
|
| Revenues (USD) | 5.99B |
| Cost of Revenue | 150.91B |
| Gross Profit | 40.15B |
| Operating Expenses | 19.02B |
| Research and Development Expense | 10.23B |
| Selling, General and Administrative Expense | 8.79B |
| Operating Income | 21.13B |
| Interest Expense | 1.85B |
| Income Tax Expense | 4.17B |
| Net Income | 21.07B |
| Net Income Common Stock | 21.07B |
| Net Income Common Stock (USD) | 660.85M |
| Consolidated Income | 21.07B |
| Earnings per Basic Share | 24.00 |
| Earnings per Basic Share (USD) | 0.75 |
| Earnings per Diluted Share | 23.05 |
| Earning Before Interest & Taxes (EBIT) | 27.09B |
| Earning Before Interest & Taxes (USD) | 849.84M |
| Weighted Average Shares | 4.51B |
| Weighted Average Shares Diluted | 4.51B |
| Balance Sheet |
| Cash and Equivalents | 91.29B |
| Cash and Equivalents (USD) | 2.86B |
| Investments | 83.93B |
| Investments Current | 16.08B |
| Investments Non-Current | 67.85B |
| Trade and Non-Trade Receivables | 143.32B |
| Current Assets | 360.40B |
| Property, Plant & Equipment Net | 531.81B |
| Total Assets | 1.07T |
| Debt Current | 71.85B |
| Total Debt | 296.44B |
| Current Liabilities | 336.80B |
| Debt Non-Current | 224.59B |
| Total Liabilities | 652.14B |
| Shareholders Equity | 389.21B |
| Shareholders Equity (USD) | 12.21B |
| Assets Non-Current | 710.94B |
| Total Debt (USD) | 9.30B |
| Goodwill and Intangible Assets | 66.28B |
| Inventory | 86.27B |
| Liabilities Non-Current | 315.34B |
| Trade and Non-Trade Payables | 99.52B |
| Cash Flow |
| Depreciation, Amortization & Accretion | 20.00B |
| Net Cash Flow from Financing | 39.15B |
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.48B |
| Capital Expenditure | -79.85B |
| Issuance (Repayment) of Debt Securities | 39.86B |
| Net Cash Flow from Investing | -83.08B |
| Net Cash Flow from Operations | 47.01B |
| Effect of Exchange Rate Changes on Cash | 397.00M |